Optical Biopsy for Peritoneal Nodules in Colorectal Patients
Use of Probe-based Confocal Laser Endomicroscopy to Perform Optical Biopsy for Peritoneal Nodules in Colorectal Cancer Patients During Surgery
1 other identifier
interventional
278
1 country
1
Brief Summary
During surgery, peritoneal metastasis is typically confirmed pathologically through resection sample. However, this process can be time-consuming when utilizing intro-operative frozen section pathology. To address this issue, we propose utilizing confocal laser endomicroscopy to provide in situ, real-time, and in-vivo diagnosis of suspected peritoneal nodules as cancer metastasis during surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable colorectal-cancer
Started Sep 2022
Longer than P75 for not_applicable colorectal-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2022
CompletedFirst Submitted
Initial submission to the registry
May 19, 2023
CompletedFirst Posted
Study publicly available on registry
May 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2027
ExpectedAugust 23, 2023
August 1, 2023
1 year
May 19, 2023
August 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of pCLE optical biopsy
The investigators will use pCLE optical biopsy for peritoneal nodules in colorectal cancer patients and compare the pathological diagnosis between optical biopsy and surgically resected specimens.
7 days
Secondary Outcomes (2)
Sensitivity, specificity of pCLE optical biopsy
7 days
The positive predictive value and negative predictive value of pCLE optical biopsy
7 days
Study Arms (1)
Probe-based confocal laser endomicroscopy biopsy
EXPERIMENTALIn this study , pCLE-based optical biopsy will be successively performed for peritoneal nodules in colorectal cancer patients during surgical operation.
Interventions
After intravenous injection of fluorescein sodium, pCLE-based optical biopsy will be performed.
Eligibility Criteria
You may qualify if:
- Age from over 18 to under 85 years
- American Society of Anesthesiology (ASA) score class I,II,or III
- Colorectal cancer
- Patients who be about to undergo surgical treatment
- Written informed consent
You may not qualify if:
- Pregnant or lactating women
- Acute renal insufficiency or stage II to IV chronic renal insufficiency
- Patients with severe liver damage
- Asthma patients or patients with allergic constitution
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, 510000, China
Related Publications (2)
Al-Mansour MR, Caycedo-Marulanda A, Davis BR, Alawashez A, Docimo S, Qureshi A, Tsuda S. SAGES TAVAC safety and efficacy analysis confocal laser endomicroscopy. Surg Endosc. 2021 May;35(5):2091-2103. doi: 10.1007/s00464-020-07607-3. Epub 2020 May 13.
PMID: 32405892BACKGROUNDBaratti D, Kusamura S, Pietrantonio F, Guaglio M, Niger M, Deraco M. Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review. Crit Rev Oncol Hematol. 2016 Apr;100:209-22. doi: 10.1016/j.critrevonc.2016.01.017. Epub 2016 Jan 22.
PMID: 26867984BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jun Yan, M.D., Ph.D.
Nanfang Hospital, Southern Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2023
First Posted
May 30, 2023
Study Start
September 15, 2022
Primary Completion
September 15, 2023
Study Completion (Estimated)
December 15, 2027
Last Updated
August 23, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share